Ccr6对咪喹莫特诱导的皮肤病变发展并非必需,尽管影响IL-22产生细胞的表皮归巢
本研究在咪喹莫特诱导的银屑病样小鼠模型中探究Ccr6的作用,发现Ccr6缺陷小鼠表皮IL-22产生减少(因γδ T细胞募集不足),但并未免受银屑病样病变保护;Ccr6对表皮而非真皮培养细胞的Il22表达关键,且对Ccr6阳性细胞(可能为γδ T细胞亚群)的表皮归巢必需。
要点
- Ccr6缺陷小鼠在咪喹莫特模型中表皮IL-22减少但皮肤病变未减轻
- Ccr6对表皮(而非真皮)细胞Il22表达关键
- Ccr6阳性细胞(可能γδ T细胞亚群)表皮归巢依赖Ccr6
核心结论
- Ccr6对咪喹莫特诱导的皮肤病变发展并非必需,尽管其影响IL-22产生细胞的表皮归巢。
研究设计与样本
- 在Ccr6缺陷小鼠上应用咪喹莫特诱导银屑病样模型,并与野生型比较。
- 利用Ccr6-LacZ敲入小鼠及Rag1-/-小鼠表皮与真皮原代培养,离体刺激评估IL-22产生。
主要发现
- Ccr6缺陷小鼠表皮IL-22产生减少,源于γδ T细胞募集不足,但未免受银屑病样病变保护。
- 离体刺激下,Ccr6对表皮培养细胞的Il22表达关键,对真皮培养细胞则不然。
- Ccr6阳性细胞(可能为γδ T细胞亚群)的表皮归巢需要Ccr6,该亚群是表皮主要潜在IL-22来源。
- Rag1-/-小鼠表皮与真皮原代培养中,表达Ccr6的先天淋巴样细胞亚群是主要潜在IL-22来源。
临床怎么用
- 提示靶向Ccr6可能不足以阻断咪喹莫特诱导的银屑病样皮肤炎症。
- 评估IL-22来源时需区分表皮与真皮微环境的不同调控机制。
局限性
- 研究仅基于咪喹莫特诱导的小鼠模型,结论外推至人类银屑病需谨慎。
- 未明确Ccr6非依赖的病变发展机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Expression of the chemokine receptor Ccr6 is shared by most IL-22-producing cells, and Ccr6-deficient mice showed decreased IL-22 production and skin inflammation upon IL-23 intradermal injections. To determine whether this observation might be extended to another psoriasis model, we applied imiquimod on Ccr6-deficient mice. Although epidermal IL-22 production was decreased because of a deficient recruitment of γδ T cells in these mice, they were not protected against psoriatic lesions. When primary epidermis or dermis tissue culture cells from nontreated mice were stimulated ex vivo with IL-1α/IL-2/IL-23, we observed that Ccr6 is crucial for Il22 expression from epidermal but not dermal cultures. Taking advantage of Ccr6-LacZ-knock-in mice, we showed that Ccr6 is necessary for the homing of Ccr6-positive cells, probably a γδ T-cell subset, which represents the main potential IL-22 source in the epidermis. Similar results were observed in Rag1-/- epidermis and dermis primary cultures, in which a subset of innate lymphoid cells expressing Ccr6 represents the main potential source of IL-22. Taken together, our data show that Ccr6 is not required for the development of skin lesions induced by imiquimod despite its effect on epidermal homing of IL-22-producing cells.
引用
- Cochez PM, Michiels C, Hendrickx E, et al. Ccr6 Is Dispensable for the Development of Skin Lesions Induced by Imiquimod despite its Effect on Epidermal Homing of IL-22-Producing Cells. J Invest Dermatol. 2017. PMID: 28115058. doi:10.1016/j.jid.2016.12.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。